EP3415531
BCMA (CD269/TN FRSFl 7) - MÓTEFNAVAKABINDANDI PRÓTEIN
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
24.5.2012EP published:
6.9.2023EP application number:
18163942.8
EP translation filed:
7.9.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
23.5.2032Expiry date:
23.5.2027Next due date:
31.5.2027
Title in English:
BCMA (CD269/TNFRSF17) - BINDING PROTEINSLanguage of the patent:
English
Timeline
Today
24.5.2012EP application
6.9.2023EP Publication
7.9.2023Translation submitted
15.11.2023Registration published
23.5.2027Expires
Owner
Name:
Glaxo Group LimitedAddress:
GSK Medicines Research Centre Gunnels Wood Road, Stevenage SG1 2NY, GB
Inventor
Name:
ALGATE, PaulAddress:
Issaquah, WA, US
Name:
CLEGG, Stephanie JaneAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
CRAIGEN, Jennifer L.Address:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
HAMBLIN, Paul AndrewAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
LEWIS, Alan PeterAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
PARMAR, Radha ShahAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Name:
MAYES, PatrickAddress:
Collegeville, PA 19426-0989, US
Name:
WATTAM, Trevor Anthony KennethAddress:
Stevenage, Hertfordshire SG1 2NY, GB
Agent
Name:
Tego IP ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201161490732 PDate:
27.5.2011Country:
US
Number:
201261647196 PDate:
15.5.2012Country:
US
Supplementary protection
SPC number:
SPC439
Classification
Categories:
C07K 16/28, A61K 39/00, A61K 47/68
Annual fees
Number
Paid
Expires
Payer
Number: 13
Paid: 19.4.2024
Expires: 23.5.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 13.5.2025
Expires: 23.5.2026
Payer: Árnason Faktor ehf.
Number: 15
Paid: 13.5.2026
Expires: 23.5.2027
Payer: Árnason Faktor ehf.